SCHEMBL20427747

SCHEMBL20427747

c1cncc(-c2cc(-n3c4ccccc4c4ccccc43)cc(-c3cccnc3)n2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 3/20 0.57
▸ CYP11B1 P15538 2/20 0.46
▸ DHODH Q02127 1/20 0.45
▸ CYP11B2 P19099 3/20 0.44
▸ CYP2A6 P11509 4/20 0.44
▸ CYP2C9 P11712 3/20 0.43
▸ MAPT P10636 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ CYP2E1 P05181 1/20 0.42
▸ CYP2B6 P20813 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ METAP2 P50579 1/20 0.41
▸ SIRT3 Q9NTG7 1/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ PIM3 Q86V86 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16303707 0.97 CYP19A1 (0.58) CYP19A1CYP11B1DHODHCYP11B2CYP2A6
SCHEMBL21973988 0.93 CYP19A1 (0.60) CYP19A1CYP11B1DHODHCYP11B2CYP2A6
SCHEMBL16362430 0.92 CYP19A1 (0.49) CYP19A1CYP11B1DHODHCYP11B2CYP2A6
SCHEMBL25768825 0.90 CYP19A1 (0.61) CYP19A1CYP11B1DHODHCYP11B2CYP2A6
SCHEMBL16749797 0.90 KMT2A (0.47) CYP19A1CYP11B1CYP11B2CYP2C9MAPT
SCHEMBL15684028 0.90 CYP19A1 (0.47) CYP19A1CYP11B1DHODHCYP11B2CYP2C9
SCHEMBL15749894 0.90 CYP2A6 (0.48) CYP19A1CYP11B2CYP2A6MAPTKDM4E
SCHEMBL24252584 0.89 CYP19A1 (0.48) CYP19A1CYP11B1DHODHCYP11B2CYP2A6
SCHEMBL25768827 0.88 CYP19A1 (0.58) CYP19A1CYP11B1DHODHCYP11B2CYP2A6
SCHEMBL21973746 0.88 CYP19A1 (0.61) CYP19A1CYP11B1DHODHCYP11B2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU CYP19A1 870/4885CYP11B1 949/4885DHODH 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback